Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / GROW THERAPY

GROW THERAPY

Series D+US
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$150Msum of rounds with a disclosed amount only
Named investors
3
Financing history
1 rounds
  1. Mar 3, 2026
    SERIES D · $150M (disclosed)
    Signalfire (participant)Menlo Ventures (participant)BCI (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “GROW THERAPY RAISES $150 MILLION IN SERIES D AS IT SOLIDIFIES NEW FLAGSHIP PARTNERSHIPS”
Investors on record
3 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Mar 3, 2026
    GROW THERAPY announced SERIES D of $150,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company